Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
1334 participants
OBSERVATIONAL
2025-05-02
2026-10-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comprehensive Geriatric Assessment and Complications Following Lung Resection for Lung Cancer
NCT01956331
Prevalence and Incidence of Central Airway Obstruction in Advanced Lung Cancer
NCT01799395
National Lung Cancer Registry in Men and Women Based on Diagnosis in Algeria
NCT02725892
The Role of Interventional Pulmonology, Microbiota and Immune Response in the Patient With Lung Cancer
NCT05164445
Detection of Circulating Tumour Cells, Spread Through Air Space in Patients With Lung Cancer
NCT06833632
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Patients receiving health care in the departments of pulmonology, oncology, radiation oncology and thoracic surgery, whose diagnosis is confirmed histologically and/or by cytology, at least 3 months before the inclusion date
* Informed consent
Exclusion Criteria
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Multidisciplinary Consultation Meeting Thoracic Oncology of the Abderrahmen Mami Hospital (ROTHAM)
UNKNOWN
Tunisian Society of Respiratory Diseases and Allergology
UNKNOWN
Tunisian Society of Medical Oncology
UNKNOWN
Dacima Consulting
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Soraya Fenniche, MD
Role: STUDY_CHAIR
Multidisciplinary consultation meeting Thoracic of the Abderrahmen Mami ROTHA Hospital
Nesrine Mejri, MD
Role: STUDY_CHAIR
Multidisciplinary consultation meeting Thoracic of the Abderrahmen Mami ROTHA Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tunisian Society of Medical Oncology
Aryanah, , Tunisia
Tunisian Society of Respiratory Diseases and Allergology
Tunis, , Tunisia
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
DAC-01-LUNGTUN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.